Abstract:The identification of mutations that enhance antibody affinity while maintaining high antibody specificity and stability is a time-consuming and laborious process. Here, we report an efficient methodology for systematically and rapidly enhancing the affinity of antibody variable domains while maximizing specificity and stability using novel synthetic antibody libraries. Our approach first uses computational and experimental alanine scanning mutagenesis to identify sites in the complementarity-determining regions (CDRs) that are permissive to mutagenesis while maintaining antigen binding. Next, we mutagenize the most permissive CDR positions using degenerate codons to encode wild-type residues and a small number of the most frequently occurring residues at each CDR position based on natural antibody diversity. This mutagenesis approach results in antibody libraries with variants that have a wide range of numbers of CDR mutations, including antibody domains with single mutations and others with tens of mutations. Finally, we sort the modest size libraries (~10 million variants) displayed on the surface of yeast to identify CDR mutations with the greatest increases in affinity. Importantly, we find that single-domain (VHH) antibodies specific for the α-synuclein protein (whose aggregation is associated with Parkinson’s disease) with the greatest gains in affinity (>5-fold) have several (four to six) CDR mutations. This finding highlights the importance of sampling combinations of CDR mutations during the first step of affinity maturation to maximize the efficiency of the process. Interestingly, we find that some natural diversity mutations simultaneously enhance all three key antibody properties (affinity, specificity, and stability) while other mutations enhance some of these properties (e.g., increased specificity) and display trade-offs in others (e.g., reduced affinity and/or stability). Computational modeling reveals that improvements in affinity are generally not due to direct interactions involving CDR mutations but rather due to indirect effects that enhance existing interactions and/or promote new interactions between the antigen and wild-type CDR residues. We expect that natural diversity mutagenesis will be useful for efficient affinity maturation of a wide range of antibody fragments and full-length antibodies.

Improved Affinity of a Chicken Single-Chain Antibody to Avian Infectious Bronchitis Virus by Site-Directed Mutagenesis of Complementarity-Determining Region H3

Improving Antibody Affinity Through in Vitro Mutagenesis in Complementarity Determining Regions

Development and experimental validation of computational methods for human antibody affinity enhancement

Key Mutations Stabilize Antigen-Binding Conformation During Affinity Maturation of A Broadly Neutralizing Influenza Antibody Lineage

Facile Affinity Maturation of Antibody Variable Domains Using Natural Diversity Mutagenesis

The Study of a Reshaping Anti-CD28 Heavy-chain Variable Domain(VH) Antibody with CDR Mutations

In Vitro Molecular Evolution of AL NEIBMs Improved Immunoglobulin (ig) Binding and Antibody Detection

Single-amino-acid Mutation in the HA Alters the Recognition of H9N2 Influenza Virus by a Monoclonal Antibody

Nanobody Affinity Improvement: Directed Evolution of the Anti-Ochratoxin A Single Domain Antibody.

Neutralization Analysis of a Chicken Single-Chain Variable Fragment Derived from an Immune Antibody Library Against Infectious Bronchitis Virus

Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation

[Improving the Affinity of an Anti-Tnf-alpha Scfv by Random Mutation].

Improved Affinity of a Human Anti-Entamoeba Histolytica Gal/GalNAc Lectin Fab Fragment by a Single Amino Acid Modification of the Light Chain.

Optimization and Modification of Anti-Rhtnf-α Single Chain Variable Fragment Antibody: Effective in Vitro Affinity Maturation and Functional Expression of Chimeric Fab.

Insights from a VHH and VNAR Study

Homology Modeling-Based in Silico Affinity Maturation Improves the Affinity of a Nanobody

Molecular basis for thermal stability and affinity in a VHH: contribution of the framework region and its influence in the conformation of the CDR3

affinity maturation of the HIV-1 Env-binding domain of CD4

P.302 Heat Shock Cognate Protein 70 May Mediate the Entry of Hepatitis E Virus into Host Cells

Transducing the Affinity of Antigen Recognition into Graded Structural Modifications of the Antibody Product (43.21)

Genetic engineering of high affinity anti-human colorectal tumour mouse/human chimeric antibody.